Viewing Study NCT01424332

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:41 PM
Ignite Modification Date: 2026-02-04 @ 12:33 PM
Study NCT ID: NCT01424332
Status: COMPLETED
Last Update Posted: 2011-08-29
First Post: 2011-08-01
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: To Evaluate Whether Acetyl Salicylic Acid (Aspirin) and Darexaban (YM150) Interact in Their Effects
Sponsor: Astellas Pharma Inc
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Pharmacodynamic and Pharmacokinetic Interaction View
None Healthy Subjects View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Pharmacodynamics View
None pharmacokinetics View
None darexaban View
None Acetyl Salicylic Acid View
None darexaban glucuronide View
None YM150 View
None YM-222714 View
None Phase 1 View